You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Drug Price Trends for ACETAMINOPHEN ER


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ACETAMINOPHEN ER

Average Pharmacy Cost for ACETAMINOPHEN ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ACETAMINOPHEN ER 650 MG CAPLET 00904-7314-60 0.06908 EACH 2025-03-19
ACETAMINOPHEN ER 650 MG CAPLET 70010-0160-01 0.06908 EACH 2025-03-19
ACETAMINOPHEN ER 650 MG TABLET 68001-0495-00 0.06908 EACH 2025-03-19
ACETAMINOPHEN ER 650 MG CAPLET 49483-0699-01 0.06908 EACH 2025-03-19
ACETAMINOPHEN ER 650 MG TABLET 68084-0777-95 0.06908 EACH 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Acetaminophen ER Market Analysis and Price Projections

Market Overview

Acetaminophen, commonly known as paracetamol, is a widely used analgesic and antipyretic drug. The extended-release (ER) formulation of acetaminophen is particularly popular due to its prolonged pain relief and convenience. Here’s a comprehensive analysis of the acetaminophen ER market, including its current state, growth drivers, challenges, and price projections.

Market Size and Growth

The global acetaminophen market, which includes the ER formulation, is substantial and growing. As of 2024, the market size was valued at approximately USD 10.83 billion and is expected to cross USD 19.19 billion by 2037, growing at a Compound Annual Growth Rate (CAGR) of more than 4.5% during the forecast period of 2025-2037[1].

Growth Drivers

Increasing Population and Health Issues

The global population is growing at a rate of nearly 1% annually, leading to an increased demand for healthcare services and medications like acetaminophen. The Asia Pacific region, in particular, is expected to dominate the market with over 32% revenue share by 2037 due to its large and growing population and general health issues[1].

Government Initiatives

Government campaigns aimed at increasing health awareness and making quality healthcare accessible are driving the demand for acetaminophen. In regions like China, the growing pharmaceutical demands, coupled with the chronic disease burden, are expected to boost the market[1].

Combination Therapies

Acetaminophen is often sold in combination with other pain-relieving drugs, which increases its usage and demand. This combination therapy is particularly common in the Asia Pacific region, contributing to the market's growth[1].

Challenges

Regulatory Pressures

Regulatory actions can significantly impact the pricing and availability of acetaminophen. For instance, in India, the National Pharmaceutical Pricing Authority (NPPA) has intervened to control price hikes, leading to fluctuations in the market[2].

Global Economic Conditions

Economic downturns, such as recessions and inflation, can reduce consumer confidence and demand for acetaminophen. This was evident in the second half of 2023, where weak global economic conditions led to a decline in acetaminophen prices[2].

Supply Chain Disruptions

Supply chain issues, including logistical challenges and trade disruptions, can affect the production and distribution of acetaminophen. Events like the lockdown in Shanghai and drought in the Panama Canal have previously impacted the market[2].

Price Trends

Recent Price Movements

In the second quarter of 2024, acetaminophen prices in North America declined due to global oversupply and reduced demand from international buyers. In contrast, prices in Asian countries, particularly India, were controlled by government interventions to prevent exponential rises[2].

Future Projections

Analysts predict that the price trend of acetaminophen will follow a weak trajectory in the upcoming quarters due to slow downstream orders and challenging global trading dynamics. However, the cost of raw materials and fluctuations in manufacturing rates may lead to a rise in prices as existing inventories deplete[2].

Regional Variations

  • Asia: Prices are expected to surge in the forthcoming quarter, driven by increased demand from the pharmaceutical sector and government policies. However, previous interventions by authorities like the NPPA have kept prices in check[2].
  • North America and Europe: These regions have seen declining prices due to oversupply and weak demand. Economic conditions and logistical challenges have also played a role in these price trends[2].

Market Segmentation

Dosage Forms

The acetaminophen market is segmented by dosage forms, with tablets and liquid suspensions being the most common. Extended-release tablets, in particular, are popular for their analgesic effects and convenience[1][3].

Regional Markets

The Asia Pacific region currently holds the highest market share, followed by North America. The Middle East and Latin America are also showing significant growth due to the establishment of manufacturing plants and increasing health issues[1][4].

Key Players and Market Competition

The acetaminophen market is moderately competitive with high entry barriers due to high initial costs and government regulations. Key players in the market include major pharmaceutical companies that dominate the production and distribution of acetaminophen[4].

Health and Safety Considerations

While acetaminophen is widely used for pain relief, its heavy usage can lead to serious adverse effects and toxicity. This highlights the need for careful dosage and monitoring, which can impact market dynamics as regulatory bodies and healthcare providers emphasize safe usage practices[3].

Analyst Insights

According to analysts, the demand for acetaminophen is expected to grow steadily due to increasing awareness of palliative care and the prevalence of pain in advanced disease conditions. However, the market will face challenges from global economic conditions, supply chain disruptions, and regulatory pressures[2][3].

Key Takeaways

  • The global acetaminophen market is projected to grow significantly, driven by population growth and increasing health issues.
  • The Asia Pacific region is expected to dominate the market due to its large population and general health problems.
  • Price trends will be influenced by global economic conditions, supply chain disruptions, and regulatory actions.
  • Extended-release tablets are a popular dosage form due to their convenience and analgesic effects.
  • The market is moderately competitive with high entry barriers.

FAQs

Q: What is the projected market size of the acetaminophen market by 2037?

A: The acetaminophen market is expected to cross USD 19.19 billion by 2037[1].

Q: Which region is expected to dominate the acetaminophen market by 2037?

A: The Asia Pacific region is expected to dominate the market with over 32% revenue share by 2037[1].

Q: What are the primary drivers of the acetaminophen market growth?

A: The primary drivers include increasing population, general health issues, and government initiatives to increase health awareness[1].

Q: How do regulatory actions impact the acetaminophen market?

A: Regulatory actions, such as price controls by authorities like the NPPA, can significantly impact the pricing and availability of acetaminophen[2].

Q: What are the potential challenges facing the acetaminophen market?

A: Challenges include global economic conditions, supply chain disruptions, and the potential for adverse effects due to heavy usage[2][3].

Sources

  1. Research Nester: Acetaminophen Market Size & Share, Growth Trends 2037
  2. Procurement Resource: Acetaminophen Price Trend and Forecast
  3. Future Market Insights: Acetaminophen API Market Share, Trends & Forecast 2033
  4. Profshare Market Research: Acetaminophen Paracetamol Market Analysis & Forecast 2025-2031

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.